(ICHN) MSCI China USD Acc - Overview
Etf: Technology, Consumer, Financials, Communication, Healthcare
| Risk 5d forecast | |
|---|---|
| Volatility | 20.9% |
| Relative Tail Risk | -7.58% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.77 |
| Alpha | 16.02 |
| Character TTM | |
|---|---|
| Beta | 0.303 |
| Beta Downside | 0.378 |
| Drawdowns 3y | |
|---|---|
| Max DD | 25.89% |
| CAGR/Max DD | 0.41 |
Description: ICHN MSCI China USD Acc January 12, 2026
The iShares MSCI China UCITS ETF (ticker ICHN) is a Netherlands-domiciled exchange-traded fund that tracks the Morningstar China Total Market Ex-Net Return (USD) Index, providing investors with broad exposure to Chinese equities across large-, mid- and small-cap stocks.
Key quantitative details (as of Q4 2024) that complement the basic description are: • Expense ratio ≈ 0.20 % (iShares standard for China-focused UCITS funds). • Assets under management ≈ €5.2 bn, reflecting strong inflows driven by renewed foreign interest in China’s consumer and technology recovery. • Top sector weights: Consumer Discretionary (~22 %), Information Technology (~18 %), and Financials (~15 %), with the ETF’s performance closely tied to China’s GDP growth outlook (≈ 4.5 % YoY projected for 2024) and policy support for domestic consumption. These figures are based on publicly available fund fact-sheets and macro-economic forecasts; exact numbers may vary as the fund reports quarterly.
If you want a deeper, data-driven view of ICHN’s risk-return profile and how it fits into a diversified portfolio, a quick look at ValueRay’s analytical dashboard can be a useful next step.
What is the price of ICHN shares?
Over the past week, the price has changed by -1.95%, over one month by -2.48%, over three months by -2.73% and over the past year by +27.70%.
Is ICHN a buy, sell or hold?
What are the forecasts/targets for the ICHN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 6.5 | 2.9% |
ICHN Fundamental Data Overview February 03, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 3.99b USD (3.99b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 3.99b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 3.99b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 7.03% (E(3.99b)/V(3.99b) * Re(7.03%) + (debt-free company))
Discount Rate = 7.03% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)